Sirnaomics to Seek Shareholder Approval for 2026 RSU and Share Option Schemes at 30 June EGM

Bulletin Express06-12

Sirnaomics Ltd. has issued a proxy form outlining the agenda for its upcoming extraordinary general meeting scheduled for 30 June 2026 at 2:30 p.m. in Hong Kong Science Park. Shareholders will vote on a series of ordinary resolutions designed to overhaul the company’s employee equity incentive framework.

The Board is requesting approval for two new long-term incentive plans: the 2026 RSU Scheme and the 2026 Share Option Scheme. If endorsed, directors will be authorized to undertake all actions necessary to implement these programmes.

Concurrently, the company is proposing to terminate both the 2022 RSU Scheme and the 2022 Share Option Scheme, signalling a strategic shift toward updated equity incentives.

A separate resolution seeks approval of the Scheme Mandate Limit, which will set the ceiling for the number of shares that can be issued under the new schemes.

Eligible shareholders may appoint one or more proxies to vote on their behalf. Proxy forms must be lodged with the company’s share registrar no later than 48 hours before the meeting. Attendance in person remains an option for shareholders who choose not to rely on proxy voting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1153559584?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-12 17:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1153559584","market":"us","top_or_hot":-1,"title":"Sirnaomics to Seek Shareholder Approval for 2026 RSU and Share Option Schemes at 30 June EGM","media":"Bulletin Express","content":"<p>Sirnaomics Ltd. has issued a proxy form outlining the agenda for its upcoming extraordinary general meeting scheduled for 30 June 2026 at 2:30 p.m. in Hong Kong Science Park. Shareholders will vote on a series of ordinary resolutions designed to overhaul the company’s employee equity incentive framework.</p>\n<p>The Board is requesting approval for two new long-term incentive plans: the 2026 RSU Scheme and the 2026 Share Option Scheme. If endorsed, directors will be authorized to undertake all actions necessary to implement these programmes.</p>\n<p>Concurrently, the company is proposing to terminate both the 2022 RSU Scheme and the 2022 Share Option Scheme, signalling a strategic shift toward updated equity incentives.</p>\n<p>A separate resolution seeks approval of the Scheme Mandate Limit, which will set the ceiling for the number of shares that can be issued under the new schemes.</p>\n<p>Eligible shareholders may appoint one or more proxies to vote on their behalf. Proxy forms must be lodged with the company’s share registrar no later than 48 hours before the meeting. Attendance in person remains an option for shareholders who choose not to rely on proxy voting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sirnaomics to Seek Shareholder Approval for 2026 RSU and Share Option Schemes at 30 June EGM</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSirnaomics to Seek Shareholder Approval for 2026 RSU and Share Option Schemes at 30 June EGM\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-12 17:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sirnaomics Ltd. has issued a proxy form outlining the agenda for its upcoming extraordinary general meeting scheduled for 30 June 2026 at 2:30 p.m. in Hong Kong Science Park. Shareholders will vote on a series of ordinary resolutions designed to overhaul the company’s employee equity incentive framework.</p>\n<p>The Board is requesting approval for two new long-term incentive plans: the 2026 RSU Scheme and the 2026 Share Option Scheme. If endorsed, directors will be authorized to undertake all actions necessary to implement these programmes.</p>\n<p>Concurrently, the company is proposing to terminate both the 2022 RSU Scheme and the 2022 Share Option Scheme, signalling a strategic shift toward updated equity incentives.</p>\n<p>A separate resolution seeks approval of the Scheme Mandate Limit, which will set the ceiling for the number of shares that can be issued under the new schemes.</p>\n<p>Eligible shareholders may appoint one or more proxies to vote on their behalf. Proxy forms must be lodged with the company’s share registrar no later than 48 hours before the meeting. Attendance in person remains an option for shareholders who choose not to rely on proxy voting.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02257","symbol_name":"圣诺医药-B","start_time":0,"source_url":"","article_id":"1153559584","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1153559584","pubTimestamp":1781257367,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Sirnaomics Ltd. has issued a proxy form outlining the agenda for its upcoming extraordinary general meeting scheduled for 30 June 2026 at 2:30 p.m. in Hong Kong Science Park. Shareholders will vote...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02257":"圣诺医药-B"},"translate_title":"Sirnaomics将于6月30日股东特别大会上寻求股东批准2026年受限制股份单位和购股权计划","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02257":1},"content_text":"Sirnaomics Ltd. has issued a proxy form outlining the agenda for its upcoming extraordinary general meeting scheduled for 30 June 2026 at 2:30 p.m. in Hong Kong Science Park. Shareholders will vote on a series of ordinary resolutions designed to overhaul the company’s employee equity incentive framework.\nThe Board is requesting approval for two new long-term incentive plans: the 2026 RSU Scheme and the 2026 Share Option Scheme. If endorsed, directors will be authorized to undertake all actions necessary to implement these programmes.\nConcurrently, the company is proposing to terminate both the 2022 RSU Scheme and the 2022 Share Option Scheme, signalling a strategic shift toward updated equity incentives.\nA separate resolution seeks approval of the Scheme Mandate Limit, which will set the ceiling for the number of shares that can be issued under the new schemes.\nEligible shareholders may appoint one or more proxies to vote on their behalf. Proxy forms must be lodged with the company’s share registrar no later than 48 hours before the meeting. Attendance in person remains an option for shareholders who choose not to rely on proxy voting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1153559584","isCrawlerRequest":true}